Marked upregulation of CNIH4 (fold change, T/P > 1.5) was detected in 70% and 60% of HCC samples in the Jin-Ling (Fig. 5H) and the Xin-Hua cohorts (Fig. S10C), respectively. Here, CNIH4 is linked to hepatocellular carcinoma.